| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |